Most published studies are small, involve patients affected by obesity and/or T2DM, and may therefore not be fully generalizable to the broader PsO/PsA population
The role of retatrutide glucagon activation in energy regulation Retatrutide is unique among current GLP-1 medications because it activates the glucagon receptor
Resistance training: Lifting weights or performing resistance exercises signals the body to preserve muscle even during caloric deficit
If you experience any unusual symptoms, such as an allergic reaction or abdominal discomfort, our healthcare providers are readily available to help identify and manage any concerns promptly
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, and reduced appetite
Our guide to GLP-1 microdosing for menopause weight gain dives deeper into this connection